What is the recommended treatment for iron deficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Iron Deficiency

The gold standard treatment for iron deficiency is oral iron supplementation with 50-100 mg of elemental iron once daily, taken in the fasting state (morning), with continuation for 3 months after hemoglobin normalization to replenish iron stores. 1

Oral Iron Therapy: First-Line Treatment

Dosing Recommendations

  • Optimal dosing strategy:
    • 60-120 mg of elemental iron as a single morning dose on alternate days 1, 2
    • Take with vitamin C to improve absorption 1
    • Take between meals to maximize absorption 1

Population-Specific Dosing (CDC Recommendations)

  • Nonpregnant women and adolescent girls: 60-120 mg daily
  • School-age children: 60 mg daily
  • Adolescent boys: 120 mg daily
  • Pregnant women (preventive): 30 mg daily
  • Pregnant women (treatment): 60-120 mg daily 1

Formulations

  • Ferrous sulfate (65 mg elemental iron per tablet) is the simplest, least expensive, and most commonly prescribed form 1, 3
  • Other options include ferrous salts and ferric complexes with polysaccharides 3
  • Extended-release formulations may reduce gastrointestinal side effects 4

Monitoring Response

  1. Check hemoglobin after 2-4 weeks of treatment
    • Critical decision point: Increase in hemoglobin of ≥10 g/L after 2 weeks strongly predicts successful treatment (sensitivity 90.1%, specificity 79.3%) 1
  2. Continue monitoring every 4 weeks until hemoglobin normalizes
  3. After normalization, continue iron for 3 months to replenish stores
  4. Long-term follow-up with iron studies every 3 months during maintenance phase 1

When to Consider Intravenous Iron

Intravenous iron should be used when:

  • Oral iron is not tolerated
  • No hemoglobin increase of at least 10 g/L after 2 weeks of oral therapy
  • Malabsorption conditions present (celiac disease, post-bariatric surgery)
  • Chronic inflammatory conditions (IBD, CKD, heart failure, cancer)
  • Ongoing blood loss exceeding oral replacement capacity
  • Second and third trimesters of pregnancy when rapid repletion needed 1, 5

IV Iron Options

  • Ferric carboxymaltose: Maximum single dose 1000 mg, infused over 15 minutes 1
  • Iron sucrose: 200 mg per injection over 10-30 minutes 1
  • Iron dextran: Can replenish iron in a single infusion but carries risk of serious reactions (0.6-0.7%) 1

Identifying and Addressing Underlying Causes

Essential evaluations based on patient demographics:

  • Men and postmenopausal women: Evaluate for gastrointestinal blood loss with upper GI endoscopy and colonoscopy 1
  • Premenopausal women: Assess for heavy menstrual bleeding 1
  • All patients: Screen for malabsorption conditions and evaluate dietary intake patterns 1
  • Consider testing for H. pylori 1
  • Screen for celiac disease with tTG antibodies, especially in premenopausal women 1

Common Pitfalls to Avoid

  1. Inadequate monitoring: Failing to check hemoglobin response after 2 weeks may delay recognition of treatment failure 1
  2. Premature discontinuation: Stopping iron once hemoglobin normalizes without continuing for 3 months to replenish stores 1
  3. Overuse of blood transfusion: Should be reserved for severe symptomatic anemia or circulatory compromise 1
  4. Ignoring non-response: May indicate non-compliance, malabsorption, continued bleeding, or concurrent deficiencies 1
  5. Using inappropriate ferritin cutoffs in patients with inflammation (should use transferrin saturation <20% when ferritin is 30-100 μg/L) 1
  6. Excessive dosing: Traditional high-dose daily regimens (150-200 mg) lead to lower fractional absorption and more side effects; alternate-day dosing may improve absorption and reduce side effects 2, 6

References

Guideline

Iron Deficiency Anemia Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The management of iron deficiency in menometrorrhagia.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.